
Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk & Compliance; and Testing, Inspection & Certification. It offers health and safety, HR and employment law compliance, occupational health, and risk management software; a range of fire safety and security services; and integrated water treatment, hygiene, testing, monitoring, wastewater, and engineering services. The company is also involved in the provision of testing, inspection and risk assessment, ventilation hygiene compliance, ductwork management and fire safety, extract cleaning, asbestos consultancy, air monitoring and clearance testing, and bulk identification and sampling services. Its customers include office complexes, streets, leisure facilities, manufacturing plants and industrial estates, SMEs, local corporates and authorities, other facilities, property management providers, NHS trusts, and FTSE companies. Marlowe plc was formerly known as Marlowe Holdings Limited. The company was founded in 2015 and is headquartered in London, the United Kingdom.
Marlowe plc trades as MRLWF on OTC. The company is classified in Industrials / Security & Protection Services and reports in USD.
The current profile places the business in Security & Protection Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $304.50M of revenue and $141.10M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Marlowe plc can be compared against peers such as AMAYA Global Holdings Corp., bpost NV/SA, China Aircraft Leasing Group Holdings Limited, Capita plc, Impellam Group plc, Hyve Group Plc.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $474.53M, beta of 0.09, and return on equity of +74.5%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
MRLWF currently shows total debt of $23.20M and beta of 0.09. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.marloweplc.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.